Best GLP-1 Providers in Colorado (2026)

See by medication

Looking for a specific GLP-1? Browse Colorado providers by drug.

About GLP-1s in Colorado

Colorado has a strong telehealth framework for GLP-1 prescribing. Health First Colorado (Medicaid) limits GLP-1 coverage primarily to diabetes patients.

• •Colorado has the lowest adult obesity rate in the US at 25.1%
• •Health First Colorado covers GLP-1s mainly for diabetes
• •Telehealth GLP-1 services are widely available statewide

Top Cities for GLP-1 Treatment in Colorado

Telehealth providers ship to all Colorado addresses, but demand is highest in these metro areas:

Prefer an in-person clinic? Browse the Colorado GLP-1 clinic directory →

GLP-1 Care Access in Colorado: The Numbers

Colorado has 684 NPI-registered in-person weight-management clinics across 71 cities — 4 with an obesity-medicine taxonomy, 226 endocrinology, and 459 bariatric — alongside 103 telehealth programs that ship to Colorado addresses. The cheapest verified ongoing compounded semaglutide price available to Colorado residents is $66/mo (tirzepatide: $97/mo). Full methodology and the 50-state table: GLP-1 care access by state.

Insurance & Medicaid in Colorado

In Q1 2026, Colorado Medicaid reimbursed approximately $40,344,875 across 38,302 GLP-1 prescriptions (all covered indications, gross before rebates — federal SDUD data; full state series here).

Most insurance plans in Colorado cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro), but coverage for obesity-only indications (Wegovy, Zepbound) is much more limited and often requires prior authorization. If your insurance won't cover brand-name GLP-1s, compounded semaglutide through telehealth is typically the most affordable option at around $209/mo.

For the exact criteria, drug list, and appeal process, read our Colorado Medicaid GLP-1 coverage & prior-authorization guide. For coverage backdoors, Zepbound is FDA-approved for obstructive sleep apnea, and Wegovy for kidney and cardiovascular indications, which some plans cover even when they exclude weight-loss-only use.

Obesity in Colorado

According to CDC data, 25.1% of Colorado adults have obesity (BMI of 30 or higher). This places Colorado at #50 out of 50 states. Access to GLP-1 medications like semaglutide and tirzepatide has expanded significantly through telehealth, helping Colorado residents get clinically supervised weight loss treatment from home.

To choose a medication, compare the clinical-trial results behind each drug, see our best semaglutide and tirzepatide provider rankings, or track the next-generation GLP-1 pipeline.

Frequently Asked Questions